Omeros reported $628K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US USD 7K 140K
Adma Biologics ADMA:US USD 20K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Biomarin Pharmaceutical BMRN:US USD 186K 0
Cytokinetics CYTK:US USD 94K 1000
Dynavax Technologies DVAX:US USD 128K 1000
Heron Therapeutics HRTX:US USD 1.19M 163K
Insmed INSM:US USD 1.36M 140K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
Knight Therapeutics Inc GUD:CN CAD 607.76M 4.2M
Macrogenics MGNX:US USD 617K 2K
Mirati Therapeutics MRTX:US USD 58K 0
Omeros OMER:US USD 628K 1000
Pacira Pharmaceuticals PCRX:US USD 46K 0
Regulus Therapeutics RGLS:US USD 17K 2K
Rockwell Medical RMTI:US USD 1000 0
Sangamo Biosciences SGMO:US USD 1.67M 49K
Sarepta Therapeutics SRPT:US USD 9K 0
United Therapeutics UTHR:US USD 700K 0
Vital Therapies VTL:US USD 4K 1000